Robert T. McCormack

Dr. McCormack is Principal of RMCC, LLC, where he advises companies in liquid biopsy development and testing. Bob is also a member of the FNIH Cancer Steering Committee and co-leads its efforts to develop well-validated reference materials for ctDNA testing.

Dr. McCormack has thirty years of invitro diagnostics experience in clinical, regulatory, medical and scientific affairs. He served in R&D leadership positions at academic institutions, small biotechs, large diagnostic companies, and in the pharmaceutical sector. While at J&J he was a founding member and General Manager of Veridex, LLC, Cellular Technologies, which helped define the liquid biopsy space. Prior to Veridex he was Head of Biomarker Strategy for the Disease Interception Group in Janssen Pharmaceutical R&D, and Vice President of Clinical Affairs for Ortho-Clinical Diagnostics.

Dr. McCormack received his BS degree from the University of Wisconsin, River Falls, and his MS and PhD degrees from the University of Minnesota.